InVitro International, Inc. (IVRO)
OTCMKTS · Delayed Price · Currency is USD
0.0600
0.00 (0.00%)
At close: Oct 16, 2026
InVitro International Revenue
InVitro International had revenue of $244.14K in the quarter ending December 31, 2024, with 43.78% growth. This brings the company's total for the last twelve months to $843.81K, down -15.91% year-over-year. In the fiscal year ending September 30, 2024, InVitro International had annual revenue of $811.29K with 2.35% growth. That makes InVitro International the 43,854th largest company in the world by revenue and 6,161st in the United States.
Revenue (ttm)
843.81K
Revenue Growth
-15.91%
P/S Ratio
1.58
Revenue / Employee
52.74K
Employees
16
Market Cap
1.34M
Revenue by Geography
- United States 513.22K 63.3%
- Other Countries 298.07K 36.7%
Fiscal year ended Sep 30, 2024 See the full InVitro International breakdown
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Sep 30, 2024 | 811.29K | 18.66K | 2.35% |
| Sep 30, 2023 | 792.63K | -60.88K | -7.13% |
| Sep 30, 2022 | 853.51K | -149.89K | -14.94% |
| Sep 30, 2021 | 1.00M | -101.41K | -9.18% |
| Sep 30, 2020 | 1.10M | 52.08K | 4.95% |
| Sep 30, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Sep 30, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Sep 30, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Sep 30, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Sep 30, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. It does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| Interpace Biosciences | 36.14M |
| Psychemedics | 19.69M |
| Aspira Women's Health | 8.55M |
| Medical Imaging | 7.52M |
| ProPhase Labs | 3.85M |
| IDenta | 1.86M |
| Longduoduo Company | 1.82M |
| NovelStem International | 3.00K |
InVitro International News
- 2 months ago - A Brighter Future Is on the Way - Newsfile Corp
- 5 months ago - Continuing the Cause; Humane Global Animal Welfare - Newsfile Corp
- 10 months ago - Game Changing Signals from Global Regulatory Agencies Accompany IVRO Sales and Profit Gains - Newsfile Corp
- 1 year ago - IVRO's Q3 Packed with Positives; Sales, Profits, and U.S. Government/Global Support for Animal Welfare - Newsfile Corp
- 1 year ago - IVRO Announces Strong FY '25 First Quarter Sales & Net Income Advances - Newsfile Corp
- 1 year ago - IVRO Signs MOU to Merge With a European Based Non-Animal Testing Focused Organization - Newsfile Corp
- 1 year ago - InVitro International: Expectations Remain High for Animal Welfare & Growth Opportunities - Newsfile Corp
- 2 years ago - InVitro International Engages Askew Kabala and Company, Inc. to Further Advance Its Corporate Growth Plan - Newsfile Corp